Who Can Benefit From Genomic Testing for Cancer?

Genomic testing for cancer can be beneficial for a wide range of individuals, including:

1. Individuals with a personal history of cancer: Genomic testing can help identify specific genetic alterations driving an individual's cancer, which can inform treatment decisions and improve outcomes.

2. Individuals with a family history of cancer: Genomic testing can help identify individuals at an increased risk of developing certain types of cancer based on inherited genetic mutations. This information can guide preventive measures, screening, and early detection strategies.

3. Individuals with rare or aggressive cancers: Genomic testing can provide insights into the molecular characteristics of rare or aggressive cancers, enabling the identification of targeted therapies or clinical trials that may improve treatment outcomes.

4. Individuals considering precision oncology or personalized medicine: Genomic testing can help identify the specific genetic alterations responsible for an individual's cancer, allowing healthcare providers to select targeted therapies or therapies matched to the patient's unique tumor profile.

5. Individuals participating in clinical trials: Genomic testing can be essential in determining an individual's eligibility for clinical trials and can help identify the most appropriate treatment options based on the patient's genomic profile.

6. Individuals interested in understanding their cancer risk: For individuals with concerns about their cancer risk based on personal or family history, genomic testing can provide information about genetic factors that may influence their risk and guide appropriate preventive measures.